SEC Form D filing

Airway Therapeutics, Inc., 2026-09-09

An SEC Form D private-offering notice from Marietta, GA, a $50,584,517 filer-stated offering target in Biotech. Filed 2026-09-09. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Airway Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing zelpultide alfa, a recombinant surfactant protein D therapy for bronchopulmonary dysplasia and other respiratory and inflammatory diseases

Filed 2026-09-09Filed to raise $50,584,517First money in 2026-08-10Raised so far $43,496,282HQ (as filed) Marietta, GASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified airwaytherapeutics.com↗Named in the filing 5 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source